Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Acknowledgement to Referees

Acknowledgement to Referees American Journal of Cardiovascular Drugs (2020) 20:513–516 https://doi.org/10.1007/s40256-020-00452-8 © Springer Nature Switzerland AG 2020 Dear Reader, Welcome to the final issue of the American Journal of Cardiovascular Drugs for 2020. This year has presented many challenges and I would like to take this opportunity to thank all who have contributed to ensuring the journal has thrived despite the extraordinary circumstances that the science community, and the world in general, has faced. I would like to start by thanking the authors of the articles published in the American Journal of Cardiovascular Drugs over the course of 2020. The enthusiasm of all authors for their chosen fields and their willingness to contribute content to the journal are crucial for its continued success. The quality of published articles is also testament to the diligence of the peer reviewers, whose willingness to share their expertise ensures that the journal’s content is held to the highest standard. I would like to acknowledge the following indi- viduals who acted as reviewers for the American Journal of Cardiovascular Drugs in the last 12 months: Shikhar Agarwal, USA Farid A. Chaudhary, Pakistan Alberto Aimo, Italy Yunqing Chen, China K. E. Juhani Airaksinen, Finland Gerald Chi, USA Tausif http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

Acknowledgement to Referees

American Journal of Cardiovascular Drugs , Volume 20 (6) – Nov 18, 2020
Download PDF
4 pages

Loading next page...
 
/lp/springer-journals/acknowledgement-to-referees-EgeVeXw0rx

References (1)

Publisher
Springer Journals
Copyright
Copyright © Springer Nature Switzerland AG 2020
ISSN
1175-3277
eISSN
1179-187X
DOI
10.1007/s40256-020-00452-8
Publisher site
See Article on Publisher Site

Abstract

American Journal of Cardiovascular Drugs (2020) 20:513–516 https://doi.org/10.1007/s40256-020-00452-8 © Springer Nature Switzerland AG 2020 Dear Reader, Welcome to the final issue of the American Journal of Cardiovascular Drugs for 2020. This year has presented many challenges and I would like to take this opportunity to thank all who have contributed to ensuring the journal has thrived despite the extraordinary circumstances that the science community, and the world in general, has faced. I would like to start by thanking the authors of the articles published in the American Journal of Cardiovascular Drugs over the course of 2020. The enthusiasm of all authors for their chosen fields and their willingness to contribute content to the journal are crucial for its continued success. The quality of published articles is also testament to the diligence of the peer reviewers, whose willingness to share their expertise ensures that the journal’s content is held to the highest standard. I would like to acknowledge the following indi- viduals who acted as reviewers for the American Journal of Cardiovascular Drugs in the last 12 months: Shikhar Agarwal, USA Farid A. Chaudhary, Pakistan Alberto Aimo, Italy Yunqing Chen, China K. E. Juhani Airaksinen, Finland Gerald Chi, USA Tausif

Journal

American Journal of Cardiovascular Drugs – Springer Journals

Published: Nov 18, 2020

There are no references for this article.